Why the study?
Does Low Molecular Weight Heparin (LMWH) prophylaxis prevent venous thromboembolism in postoperative patients?
Does Low Molecular Weight Heparin (LMWH) prophylaxis prevent venous thromboembolism in postoperative patients?
Answers are grounded in this paper and cite their sources.
LMWHs are an effective, safe, and cost-effective option for postoperative VTE prophylaxis, especially in high-risk patients.
Several recently published clinical trials have shown that prophylaxis against postoperative venous thromboembolism with LMWHs is justified on the basis of proven efficacy, safety, better patient acceptability and saving of nursing time. The cost effective analyses also indicate substantial savings can be achieved by using LMWHs, particularly in the high-risk patients. It is believed that emphasis is now on the clinicians who must protect all high-risk patients.
No takes yet. Share an insight, caveat, or question.
V V Kakkar (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: